Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 CAD | -5.30% | -17.26% | -0.51% |
May. 09 | Transcript : HLS Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.51% | 91.72M | |
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+8.80% | 8.59B | |
+8.25% | 8.38B | |
-19.42% | 8.09B | |
+5.62% | 4.81B | |
+16.83% | 4.32B | |
-1.83% | 4.05B | |
+26.97% | 3.79B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Brief: Updates Its Peak-year Sales Estimate to $250-300 Million in Revenue with Adjusted EBITDA Margin of Near 30%